E. N. Manderson

发表

Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer

A. Mes-Masson, D. Provencher, P. Tonin, 2002, Molecular carcinogenesis.

Mutations in a 10‐bp polyadenine repeat of transforming growth factor β‐receptor type II gene is an infrequent event in human epithelial ovarian cancer

A. Mes-Masson, D. Provencher, P. Tonin, 2000, Clinical genetics.

A Novel Genetic Screen Implicates Elm1 in the Inactivation of the Yeast Transcription Factor SBF

Stephen W. Michnick, Mohan Malleshaiah, S. Michnick, 2008, PloS one.

Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p

A. Mes-Masson, D. Provencher, P. Tonin, 2007, Oncogene.

Universal strategies in research and drug discovery based on protein-fragment complementation assays

Stephen W. Michnick, Ingrid Remy, S. Michnick, 2007, Nature Reviews Drug Discovery.

Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.

T. Hudson, A. Mes-Masson, D. Provencher, 2002, Genome research.

Characterization of four novel epithelial ovarian cancer cell lines

A. Mes-Masson, D. Provencher, P. Tonin, 2000, In Vitro Cellular & Developmental Biology - Animal.

Molecular Genetic Analysis of a Cell Adhesion Molecule With Homology to L1CAM, Contactin 6, and Contactin 4 Candidate Chromosome 3p26pter Tumor Suppressor Genes in Ovarian Cancer

A. Mes-Masson, D. Provencher, P. Tonin, 2009, International Journal of Gynecologic Cancer.

Microarray analysis of gene expression mirrors the biology of an ovarian cancer model

Anne-Marie Mes-Masson, Thomas J Hudson, T. Hudson, 2001, Oncogene.

The quest for a tumor suppressor gene phenotype.

P. Tonin, N. Presneau, E. N. Manderson, 2003, Current molecular medicine.